Lack of association between iron metabolism and depressive mood in an elderly general population

International Psychogeriatrics

Volumn 18, Issue 3, 2006, Pages 437-444

  Baune, B T ^a   Eckardstein, A V ^a,b   Berger, K ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Biological markers; Depression; Ferritin; Inflammation; Iron; Population studies; Transferrin; Transferrin receptor

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; ELDERLY CARE; FEMALE; GERMANY; HUMAN; HYPERTENSION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MEMORY; MORBIDITY; PREVALENCE; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; IRON; MALE; RECEPTORS, TRANSFERRIN; REFERENCE VALUES; REGRESSION ANALYSIS; STATISTICS; TRANSFERRIN;

EID: 33746473997     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610205002759     Document Type: Article

References (21)

1. Beard, J. L., Wiesinger, J. A., Li, N. and Connor, J. R. (2005). Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status. Journal of Neuroscience Research, 79, 254-261.
2. Beekman, A. T., Deeg, D. J., Van Limbeek, J., Braam, A. W., De Vries, M. Z. and Van Tilburg, W. (1997). Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychological Medicine, 27, 231-235.
3. Bouhuys, A. L., Flentge, F., Oldehinkel, A. J. and van den Berg, M. D. (2004). Potential psychosocial mechanisms linking depression to immune function in elderly subjects. Psychiatry Research, 127, 237-245.
4. Brock, J. H. (1994). Iron in infection, immunity, inflammation and neoplasia. In J. H. Brock, J. W. Halliday, M. J. Pippard and L. W. Powell (Eds.) Iron Metabolism in Health and Disease (pp. 37-67). London: W. B. Saunders.
5. Fairbanks, V. F. and Beutler, E. (1988). Iron. In M. E. Shils and V. R. Young (Eds.) Modern Nutrition in Health and Disease (pp. 376-395). Philadelphia, PA: Lea and Febiger.
6. Huang, T. L. (2005). Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. Journal of Affective Disorders, 86, 75-79.
7. Keil, U, Cairns, V., Döring, A., Härtl, U., Jorcik, J. and Perz, S. (1985). MONICA Project, Region Augsburg, Manual of Operations, Survey. Munich: National Research Center for Environment and Health. (GSF25)
8. Kishnani, P. S., Boney, A. and Chen, Y. T. (1999). Nutritional deficiencies in a patient with glycogen storage disease type Ib. Journal of Inherited and Metabolic Disorders, 22, 795-801.
9. Kop, W. J. et al. (2002). Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. American Journal of Cardiology, 89, 419-424.
10. Maes, M. (1993). A review on the acute phase response in major depression. Reviews in the Neurosciences, 4, 407-416.
11. Maes, M. (1995). Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 11-38.
12. Maes, M. et al. (1991). Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression. Journal of Affective Disorders, 23, 25-33.
13. Maes, M. et al. (1993a). Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Research, 49, 151-165.
14. Maes, M. et al. (1993b). Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Research, 47, 229-241.
15. Maes, M. et al. (1995a). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders, 34, 301-309.
16. Maes, M., Meltzer, H. Y., Buckley, P. and Bosmans, E. (1995b). Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression, European Archives of Psychiatry and Clinical Neuroscience, 244, 325-329.
17. Maes, M. et al. (1996). Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. Journal of Affective Disorders, 40, 23-33.
18. Penninx, B. W. et al. (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition Study. Biological Psychiatry, 54, 566-572.
19. Portella, M. J., Harmer, C. J., Flint, J., Cowen, P. and Goodwin, G. M. (2004). Enhanced early morning salivary cortisol in neuroticism. American Journal of Psychiatry, 162, 807-809.
20. Schmidt, W. P., Roesler, A., Kretzschmar, K., Ladwig, K. H., Junker, R. and Berger, K. (2004). Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. Journal of the American Geriatrics Society, 52, 1045-1050.
21. Sluzewska, A. et al. (1996). Indicators of immune activation in major depression. Psychiatry Research, 64, 161-167.